» Articles » PMID: 35924135

Imaging Tips and Tricks in Management of Renal and Urothelial Malignancies

Overview
Publisher Thieme
Specialty Radiology
Date 2022 Aug 4
PMID 35924135
Authors
Affiliations
Soon will be listed here.
Abstract

Management of urological malignancies has evolved significantly with continually changing guidelines and treatment options which demand more centralized involvement of radiology than ever before. Radiologists play a pivotal role in interpreting complex cancer scans and guiding clinical teams toward the best management options in the light of clinical profile. Management of complex uro-oncology cases is often discussed in multidisciplinary meetings which are essential checkpoints to evaluate an overall picture and formulate optimal treatment plans. The aim of this article is to provide a radiological perspective with practical guidance to fellow radiologists participating in uro-oncology multidisciplinary meetings based on commonly encountered case scenarios, updated guidelines, and cancer pathways. Crucial imaging tips with regards to renal and urinary tract cancers, upon which therapeutic decisions are made, have been condensed in this article after reviewing several complex cases from urology multidisciplinary meetings and European Association of Urology guidelines. Outline of various diagnostic and management strategies, key staging features, surveillance guidelines, and, above all, what the onco-urologists want to know from radiologists have been succinctly discussed in this article.

References
1.
Neuzillet Y, Tillou X, Mathieu R, Long J, Gigante M, Paparel P . Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol. 2011; 60(2):366-73. DOI: 10.1016/j.eururo.2011.02.035. View

2.
Rajesh A, Sokhi H, Fung R, Mulcahy K, Bankart M . Bladder cancer: evaluation of staging accuracy using dynamic MRI. Clin Radiol. 2011; 66(12):1140-5. DOI: 10.1016/j.crad.2011.05.019. View

3.
Flanigan R, Mickisch G, Sylvester R, Tangen C, van Poppel H, Crawford E . Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol. 2004; 171(3):1071-6. DOI: 10.1097/01.ju.0000110610.61545.ae. View

4.
Rutherford E, Cast J, Breen D . Immediate and long-term CT appearances following radiofrequency ablation of renal tumours. Clin Radiol. 2008; 63(2):220-30. DOI: 10.1016/j.crad.2007.07.002. View

5.
Narayanasamy S, Krishna S, Prasad Shanbhogue A, Flood T, Sadoughi N, Sathiadoss P . Contemporary update on imaging of cystic renal masses with histopathological correlation and emphasis on patient management. Clin Radiol. 2018; 74(2):83-94. DOI: 10.1016/j.crad.2018.09.003. View